This article is about companies who buy drugs that are in short supply that are used to treat cancer patients. Then the companies that have bought the treatments that are in low supply resell it from prices that may be 650 to 4000 percent over the usual cost. In turn, hospitals that buy these products will have to pay more that they should and also charge the patient more for the treatment. The vendors act as a middleman and hike up the prices because of scarcity. In the end if the patient cannot afford the treatment, the debt will have to be covered by the hospital.
Why is it that law enforccement is not taking action to stop the reselling of the products that are extremely overpriced.
Why is it that law enforccement is not taking action to stop the reselling of the products that are extremely overpriced.
No comments:
Post a Comment